SHINE Medical Technologies has secured $50 million financing with funds managed by Oaktree Capital Management to support its upcoming medical isotope production facility and the commercialization of molybdenum-99 (Mo-99), lutetium-177 (Lu-177), and other diagnostic and therapeutic isotopes. Greg Piefer – founder and CEO of SHINE Medical Technologies said: “Oaktree has broad expertise in complex infrastructure […]
SHINE Medical Technologies, a US radioisotopes manufacturer, began construction on its first medical isotope production facility in Janesville in Wisconsin. The groundbreaking ceremony on the medical isotope production facility follows the allocation of 91 acres of land by the City of Janesville to SHINE Medical Technologies to develop the project, which is located across from […]